Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anmei Zhang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|March 2, 2021
Joint Depth and Defocus Estimation From a Single Image Using Physical ConsistencyAnmei Zhang, Jian Sun
Molecules (Basel, Switzerland)|January 30, 2014
Resveratrol-4-O-D-(2'-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathwayQichao Xie, Yupeng Yang, Zhiyi Wang, et al.
BMB Reports|November 12, 2013
Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activityYuzhong Duan, Fanglin Chen, Anmei Zhang, et al.
Frontiers in Immunology|May 30, 2023
Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancerJingyun Yang, Xiaofei Hu, Yu Wang, et al.
Annals of Translational Medicine|March 16, 2023
A real-world retrospective study of incidence and associated factors of endocrine adverse events related to PD-1/PD-L1 inhibitorsZhiyi Wang, Chunyan Hu, Anmei Zhang, et al.
Frontiers in Immunology|April 24, 2025
Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective studyJingyun Yang, Tianxiang Cui, Yang Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 10, 2023
Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trialTianxiang Cui, Anmei Zhang, Jianxiong Cui, et al.
Chinese Medical Journal|March 17, 2024
Subsequent strategies and underlying mechanism of acquired resistance to PD-1 axis inhibitors in advanced non-small cell lung cancerHuilan Wang, Xinyu Cheng, Fan Yang, et al.
Frontiers in Oncology|June 14, 2021
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor MutationsYongdong Feng, Guangkuo Zhu, Song Lang, et al.
Cancer Management and Research|December 28, 2018
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survivalXinxin Wang, Diangang Chen, Jianbao Gao, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|March 2, 2021
Joint Depth and Defocus Estimation From a Single Image Using Physical ConsistencyAnmei Zhang, Jian Sun
Molecules (Basel, Switzerland)|January 30, 2014
Resveratrol-4-O-D-(2'-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathwayQichao Xie, Yupeng Yang, Zhiyi Wang, et al.
BMB Reports|November 12, 2013
Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2 production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activityYuzhong Duan, Fanglin Chen, Anmei Zhang, et al.
Frontiers in Immunology|May 30, 2023
Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancerJingyun Yang, Xiaofei Hu, Yu Wang, et al.
Annals of Translational Medicine|March 16, 2023
A real-world retrospective study of incidence and associated factors of endocrine adverse events related to PD-1/PD-L1 inhibitorsZhiyi Wang, Chunyan Hu, Anmei Zhang, et al.
Frontiers in Immunology|April 24, 2025
Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective studyJingyun Yang, Tianxiang Cui, Yang Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 10, 2023
Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trialTianxiang Cui, Anmei Zhang, Jianxiong Cui, et al.
Chinese Medical Journal|March 17, 2024
Subsequent strategies and underlying mechanism of acquired resistance to PD-1 axis inhibitors in advanced non-small cell lung cancerHuilan Wang, Xinyu Cheng, Fan Yang, et al.
Frontiers in Oncology|June 14, 2021
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor MutationsYongdong Feng, Guangkuo Zhu, Song Lang, et al.
Cancer Management and Research|December 28, 2018
Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survivalXinxin Wang, Diangang Chen, Jianbao Gao, et al.
Pageof 2